Equifax (EFX) recently reported Q4 2025 results that surpassed analyst expectations on both EPS and revenue, and that stronger quarter has coincided with a more positive stance from analysts on the stock.

The stronger Q4 report and launch of the new myEquifax consumer app have come after a tougher stretch for shareholders, with a 30 day share price return of 11.65% and a 90 day share price return of 14.78%. At the same time, the 1 year total shareholder return of 20.61% and 3 year total shareholder return of 5.06% point to weaker longer term results from the recent peak.

If Equifax's recent move has you reassessing your watchlist, this could be a useful moment to broaden your search and check out 20 top founder-led companies

With Equifax shares down over the past year, but analysts still seeing upside to their price targets, the real question for you is whether the recent weakness signals an undervalued entry point or if the market already reflects future growth.

Most Popular Narrative: 23.2% Undervalued

Equifax's most followed narrative pegs fair value at $237.35 using a 7.81% discount rate, compared with the last close of $182.39, which sets a clear valuation gap for investors to assess.

Accelerating customer adoption of new multi-data product solutions (e.g., TWN indicator, Single Data Fabric, EFX.AI) and continued high NPI (New Product Introduction) rates are expanding Equifax's value proposition, positioning the company to capture incremental market share. Global cloud migration and investments in proprietary technology platforms are now largely complete, which is expected to enable margin expansion through operating leverage, efficiency gains, and scalable innovation over time.

Curious what kind of revenue growth, margin lift, and future earnings multiple the narrative needs to reach that fair value? The underlying model leans heavily on faster earnings compounding, higher profitability, and a premium P/E relative to the wider industry. The full narrative shows how those ingredients are combined into that $237.35 figure.

Result: Fair Value of $237.35 (UNDERVALUED)

However, this depends on legal costs staying contained and on competitive pressure from fintechs and alternative scoring models not eroding Equifax's pricing power or government related revenue.

Another Way to Look at It: Market Pricing Signals

That 23.2% undervaluation from the narrative sits beside a very different message from simple P/E math. Equifax trades at 33.3x earnings, compared with 19x for the US Professional Services industry, 30.9x for peers, and a fair ratio of 29.8x, which points to valuation risk if sentiment cools.

Put simply, the DCF and the current earnings multiple are telling two different stories about upside and downside. Which one you lean on may come down to how confident you are in the long term earnings path and how much P/E compression you are willing to tolerate along the way See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With such a mixed setup on value and sentiment, this is a moment to look at the numbers firsthand and decide where you stand, then weigh the 4 key rewards and 1 important warning sign

Looking for more investment ideas?

If Equifax is already on your radar, do not stop there. A few minutes exploring other ideas now could mean spotting opportunities you will wish you had seen earlier.

• Hunt for quality at a discount by scanning 62 high quality undervalued stocks that pair solid fundamentals with potentially appealing entry prices.
• Strengthen your income game by checking 12 dividend fortresses built around reliable, higher yielding payers.
• Prioritize resilience and sleep better at night by reviewing 67 resilient stocks with low risk scores that score well on stability and downside protection.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.